Febrikast LC Tablet is a combination medication containing Levocetirizine 5mg and Montelukast 10mg, designed to provide effective relief from allergic conditions such as allergic rhinitis and chronic asthma. Levocetirizine is a second-generation antihistamine that works by selectively blocking peripheral H1 histamine receptors, thereby reducing symptoms like sneezing, runny nose, itching, and watery eyes. Montelukast, a leukotriene receptor antagonist, helps prevent airway inflammation and bronchoconstriction by inhibiting leukotriene D4 receptors in the lungs, making it particularly useful in managing asthma and seasonal allergies. The synergistic action of these two components offers comprehensive control over allergic symptoms and improves respiratory function. Febrikast LC is typically prescribed for patients who require both antihistaminic and anti-inflammatory effects to manage their allergy-related respiratory issues effectively. It is generally well-tolerated, but patients should use it under medical supervision, especially if they have a history of liver disease or other chronic conditions. Common side effects may include headache, fatigue, or gastrointestinal discomfort. Febrikast LC Tablet should be taken as directed by a healthcare professional to ensure optimal results and minimize potential adverse effects.